Cooperativity of hydrophobic anchor interactions: Evidence for epitope selection by MHC class II as a folding process

Journal of Immunology

Volumn 178, Issue 11, 2007, Pages 7181-7189

  Ferrante, Andrea ^a   Gorski, Jack ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA DR1 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIRUS HEMAGGLUTININ;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; BINDING COMPETITION; CONFORMATIONAL TRANSITION; DISSOCIATION CONSTANT; HYDROGEN BOND; HYDROPHOBICITY; INFLUENZA VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION;

EID: 34249803281     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.11.7181     Document Type: Article

References (38)

1. Watts, C., and S. Powis. 1999. Pathways of antigen processing and presentation. Rev. Immunogenet. 1: 60-74.
2. Brocke, P., N. Garbi, F. Momburg, and G. J. Hammerling. 2002. HLA-DM, HLA-DO and tapasin: functional similarities and differences. Curr. Opin. Immunol. 14: 22-29.
3. Fremont, D. H., W. A. Hendrickson, P. Marrack, and J. Kappler. 1996. Structures of an MHC class II molecule with covalently bound single peptides. Science 272: 1001-1004.
4. Jardetzky, T. S., J. H. Brown, J. C. Gorga, L. J. Stern, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1996. Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides. Proc. Natl. Acad. Sci. USA 93: 734-738.
5. Stern, L. J., J. H. Brown, T. S. Jardetzky, J. C. Gorga, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368: 215-221.
6. Latek, R. R., A. Suri, S. J. Petzold, C. A. Nelson, O. Kanagawa, E. R. Unanue, and D. H. Fremont. 2000. Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. Immunity 12: 699-710.
7. Bian, H., J. F. Reidhaar-Olson, and J. Hammer. 2003. The use of bioinformatics for identifying class II-restricted T-cell epitopes. Methods 29: 299-309.
8. Sturniolo, T., E. Bono, J. Ding, L. Raddrizzani, O. Tuereci, U. Sahin, M. Braxenthaler, F. Gallazzi, M. P. Protti, F. Sinigaglia, and J. Hammer. 1999. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat. Biotechnol. 17: 555-561.
9. Joshi, R. V., J. A. Zarutskie, and L. J. Stern. 2000. A three-step kinetic mechanism for peptide binding to MHC class II proteins. Biochemistry 39: 3751-3762.
10. Sadegh-Nasseri, S., and H. M. McConnell. 1989. A kinetic intermediate in the reaction of an antigenic peptide and I-Ek. Nature 337: 274-276.
11. Sadegh-Nasseri, S., L. J. Stern, D. C. Wiley, and R. N. Germain. 1994. MHC class II function preserved by low-affinity peptide interactions preceding stable binding. Nature 370: 647-650.
12. Sadegh-Nasseri, S., and R. N. Germain. 1991. A role for peptide in determining MHC class II structure. Nature 353: 167-170.
13. Sadegh-Nasseri, S., and R. N. Germain. 1992. How MHC class II molecules work: peptide-dependent completion of protein folding. Immunol. Today 13: 43-46.
14. Fersht, A. R. 1999. Structure and Mechanism in Protein Science: A Guide to Enzyme Catalysis and Protein Folding W. H. Freeman, New York.
15. Anderson, M. W., and J. Gorski. 2005. Cooperativity during the formation of peptide/MHC class II complexes. Biochemistry 44: 5617-5624.
16. McFarland, B. J., J. F. Katz, A. J. Sant, and C. Beeson. 2005. Energetics and cooperativity of the hydrogen bonding and anchor interactions that bind peptides to MHC class II protein. J. Mol. Biol. 350: 170-183.
17. Stern, L. J., and D. C. Wiley. 1992. The human class II MHC protein HLA-DR1 assembles as empty α β heterodimers in the absence of antigenic peptide. Cell 68: 465-477.
18. Jensen, P. E., J. C. Moore, and A. E. Lukacher. 1998. A europium fluoroimmunoassay for measuring peptide binding to MHC class I molecules. J. Immunol. Methods 215: 71-80.
19. Creighton, T. E. 1995. Protein folding: an unfolding story. Curr. Biol. 5: 353-356.
20. Williams, D. H., M. Zhou, and E. Stephens. 2006. Ligand binding energy and enzyme efficiency from reductions in protein dynamics. J. Mol. Biol. 355: 760-767.
21. Horovitz, A., and A. R. Fersht. 1990. Strategy for analysing the co-operativity of intramolecular interactions in peptides and proteins. J. Mol. Biol. 214: 613-617.
22. Horovitz, A., and A. R. Fersht. 1992. Co-operative interactions during protein folding. J. Mol. Biol. 224: 733-740.
23. Jardetzky, T. S., J. C. Gorga, R. Busch, J. Rothbard, J. L. Strominger, and D. C. Wiley. 1990. Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding. EMBO J. 9: 1797-1803.
24. Wu, S., J. Gorski, D. D. Eckels, and D. K. Newton-Nash. 1996. T cell recognition of MHC class II-associated peptides is independent of peptide affinity for MHC and sodium dodecyl sulfate stability of the peptide/MHC complex: effects of conservative amino acid substitutions at anchor position 1 of influenza matrix protein 19-31. J. Immunol. 156: 3815-3820.
25. Zavala-Ruiz, Z., E. J. Sundberg, J. D. Stone, D. B. DeOliveira, I. C. Chan, J. Svendsen, R. A. Mariuzza, and L. J. Stern. 2003. Exploration of the P6/P7 region of the peptide-binding site of the human class II major histocompatability complex protein HLA-DR1. J. Biol. Chem. 278: 44904-44912.
26. Corper, A. L., T. Stratmann, V. Apostolopoulos, C. A. Scott, K. C. Garcia, A. S. Kang, I. A. Wilson, and L. Teyton. 2000. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science 288: 505-511.
27. Anderson, M. W., and J. Gorski. 2003. Cutting edge: TCR contacts as anchors: effects on affinity and HLA-DM stability. J. Immunol. 171: 5683-5687.
28. Natarajan, S. K., L. J. Stern, and S. Sadegh-Nasseri. 1999. Sodium dodecyl sulfate stability of HLA-DR1 complexes correlates with burial of hydrophobic residues in pocket 1. J. Immunol. 162: 3463-3470.
29. Ong, B., N. Willcox, P. Wordsworth, D. Beeson, A. Vincent, D. Altmann, J. S. Lanchbury, G. C. Harcourt, J. I. Bell, and J. Newsom-Davis. 1991. Critical role for the Val/Gly86 HLA-DR β dimorphism in autoantigen presentation to human T cells. Proc. Natl. Acad. Sci. USA 88: 7343-7347.
30. Wu, S., and J. Gorski. 1997. Polymorphism at β 85 and not β 86 of HLA-DR1 is predominantly responsible for restricting the nature of the anchor side chain: implication for concerted effects of class II MHC polymorphism. Int. Immunol. 9: 1495-1502.
31. Sato, A. K., J. A. Zarutskie, M. M. Rushe, A. Lomakin, S. K. Natarajan, S. Sadegh-Nasseri, G. B. Benedek, and L. J. Stern. 2000. Determinants of the peptide-induced conformational change in the human class II major histocompatibility complex protein HLA-DR1. J. Biol. Chem. 275: 2165-2173.
32. McFarland, B. J., C. Beeson, and A. J. Sant. 1999. Cutting edge: a single, essential hydrogen bond controls the stability of peptide-MHC class II complexes. J. Immunol. 163: 3567-3571.
33. McFarland, B. J., J. F. Katz, C. Beeson, and A. J. Sant. 2001. Energetic asymmetry among hydrogen bonds in MHC class II*peptide complexes. Proc. Natl. Acad. Sci. USA 98: 9231-9236.
34. Itzhaki, L. S., D. E. Otzen, and A. R. Fersht. 1995. The structure of the transition state for folding of chymotrypsin inhibitor 2 analysed by protein engineering methods: evidence for a nucleation-condensation mechanism for protein folding. J. Mol. Biol. 254: 260-288.
35. d-peptide complexes reveal that high affinity can be achieved without large anchor residues. Immunity 8: 319-329.
36. Kozono, H., J. White, J. Clements, P. Marrack, and J. Kappler. 1994. Production of soluble MHC class II proteins with covalently bound single peptides. Nature 369: 151-154.
37. Stryhn, A., L. O. Pedersen, T. Romme, C. B. Holm, A. Holm, and S. Buus. 1996. Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of binding. Eur. J. Immunol. 26: 1911-1918.
38. De Lano, W. L. 2002. The PyMOL Molecular Graphics System. De Lano Scientific, San Carlos, CA.